Mark Collinge
Impact in
- Immunology and Allergy top 5%
- Cell Adhesion Molecules Research
- Immunology top 10%
Papers in
- Immunology 21
- Immunotoxicology and immune responses 9
- Biosimilars and Bioanalytical Methods 6
- Immune Cell Function and Interaction 6
- T-cell and B-cell Immunology 4
-
- RNA Research and Splicing 4
- Co-authors
- Jeffrey R. Bender (15 shared papers)William C. Sessa (4 shared papers)M. Page Haynes (3 shared papers)Ruggero Pardi (10 shared papers)Kerry S. Russell (2 shared papers)David Fulton (1 shared paper)Manuel Morales‐Ruiz (1 shared paper)Mehran M. Sadeghi (3 shared papers)
- Journals
- The Journal of Immunology (3 papers)Regulatory Toxicology and Pharmacology (3 papers)Proceedings of the National Academy of Sciences (3 papers)Toxicologic Pathology (2 papers)PLoS ONE (2 papers)
- Partner nations
- United StatesItalyCanada
In The Last Decade
Mark Collinge
35 papers receiving 1.7k citations
Peers
Comparison fields: 5 of 107
- Immunology and Allergy 124
- Immunology 419
- Endocrinology, Diabetes and Metabolism 295
- Cancer Research 218
- Genetics 401
Countries citing papers authored by Mark Collinge
This map shows the geographic impact of Mark Collinge's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Collinge with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Collinge more than expected).
Fields of papers citing papers by Mark Collinge
This network shows the impact of papers produced by Mark Collinge. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Collinge. The network helps show where Mark Collinge may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark Collinge, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 37 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2000 | 477 | |
| 2 | 2003 | 264 | |
| 3 | 1999 | 148 | |
| 4 | 2000 | 117 | |
| 5 | 2006 | 76 | |
| 6 | 2007 | 70 | |
| 7 | 2001 | 64 | |
| 8 | 1998 | 55 | |
| 9 | 2013 | 51 | |
| 10 | 2012 | 48 | |
| 11 | 1995 | 48 | |
| 12 | 2014 | 34 | |
| 13 | Class II transactivator-independent endothelial cell MHC class II gene activation induced by lymphocyte adhesion. | 1998 | 33 |
| 14 | 2014 | 31 | |
| 15 | 2002 | 27 | |
| 16 | 2018 | 26 | |
| 17 | 1998 | 25 | |
| 18 | 2010 | 23 | |
| 19 | 2021 | 22 | |
| 20 | 2006 | 22 |
About Mark Collinge
Mark Collinge is a scholar working on Immunology, Molecular Biology, Small Animals, Oncology and Immunology and Allergy, having authored 37 papers that have together received 1.8k indexed citations. Recurring topics across this work include Immunotoxicology and immune responses (9 papers), Animal testing and alternatives (9 papers), Cytokine Signaling Pathways and Interactions (8 papers), Cell Adhesion Molecules Research (6 papers), Biosimilars and Bioanalytical Methods (6 papers), Immune Cell Function and Interaction (6 papers), RNA Research and Splicing (4 papers) and T-cell and B-cell Immunology (4 papers). The work is most often cited by research in Immunology and Allergy (124 citations), Immunology (419 citations), Endocrinology, Diabetes and Metabolism (295 citations), Cancer Research (218 citations) and Genetics (401 citations). Mark Collinge has collaborated with scholars based in United States, Italy and Canada. Frequent co-authors include Jeffrey R. Bender, William C. Sessa, M. Page Haynes, Ruggero Pardi, Kerry S. Russell, David Fulton, Manuel Morales‐Ruiz, Mehran M. Sadeghi, Koji Hisamoto and Roland Baron. Their work appears in journals such as The Journal of Immunology, Regulatory Toxicology and Pharmacology, Proceedings of the National Academy of Sciences, Toxicologic Pathology and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.